Bremelanotide vs hGHRH(1-37)OH

Head-to-head comparison of Bremelanotide (Bremelanotide (PT-141), cyclic melanocortin receptor agonist) and hGHRH(1-37)OH (Human growth hormone-releasing factor (1-37) hydroxyl) — benefits, dosing, side effects, research data, and where to buy.

PropertyBremelanotidehGHRH(1-37)OH
CategorySexual HealthGrowth Hormone
Full NameBremelanotide (PT-141), cyclic melanocortin receptor agonistHuman growth hormone-releasing factor (1-37) hydroxyl
Molecular Weight1025.2 DaN/A
Half-Lifeabout 2.7 h5-20 minutes
Amino Acids737
Typical Dose1.75 mg1-2 mcg/kg
RouteSubcutaneousSubcutaneous/IV
Purity≥98%≥98%
Studies Count20060
Research StatusClinicalClinical Research

Bremelanotide Benefits

  • increases sexual desire
  • supports arousal
  • may improve erectile response
  • on-demand use

hGHRH(1-37)OH Benefits

  • GH release studies
  • minimal-sequence mapping
  • receptor pharmacology
  • peptide stability research

Bremelanotide Dosing

1.75 mg subcutaneous PRN|administer about 45 minutes before activity|max 1 dose per 24 hours

hGHRH(1-37)OH Dosing

1-2 mcg/kg SC or IV bolus|acute stimulation with serial GH assays|short-course research administration with biomarker monitoring

Bremelanotide Side Effects

  • nausea
  • flushing
  • headache
  • transient blood pressure increase

hGHRH(1-37)OH Side Effects

  • flushing
  • headache
  • transient fatigue

Research Overview

Bremelanotide

Human studies and approval data support meaningful effects on sexual desire in women, with a central mechanism involving melanocortin signaling. It is one of the most clinically relevant peptides in this category and is commonly used as the reference compound for PT-141-type research.

hGHRH(1-37)OH

Human GHRF(1-37)OH has appeared in studies examining how loss of C-terminal residues affects biological activity at the GHRH receptor. It is often used alongside other fragments to define structure-activity relationships within the GHRH family.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Bremelanotide stacks with:

Kisspeptin-54Melanotan-II

hGHRH(1-37)OH stacks with:

L-arginineL-lysineglycine
melanocortinlibidoerectile-functionapprovedghrhfragmentstructure-activityendocrinology